查看完整行情页>>
|
货币单位:美元(USD)
内克塔治疗
Nektar Therapeutics (nktr)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Millennium Management LLC |
1854623 |
1.00% |
613920 |
49.48% |
2022-03-31
|
| Amvescap Plc. |
37230534 |
19.99% |
339040 |
0.92% |
2022-03-31
|
| BlackRock Fund Advisors |
28380235 |
15.24% |
-8119219 |
-22.24% |
2022-05-31
|
| BlackRock Inc |
26671803 |
14.32% |
7827559 |
41.54% |
2021-12-31
|
| Vanguard Group Inc |
19430385 |
10.43% |
918474 |
4.96% |
2022-03-31
|
| PRIMECAP Management Company |
17061822 |
9.16% |
-350600 |
-2.01% |
2022-03-31
|
| Wellington Management Company LLP |
11383721 |
6.11% |
-- |
-- |
2022-03-31
|
| State Street Corporation |
5800302 |
3.11% |
508754 |
9.61% |
2022-03-31
|
| Vanguard Investments Australia Ltd |
5489221 |
2.95% |
-1166 |
-0.02% |
2022-05-31
|
| Bellevue Asset Management AG |
4888106 |
2.62% |
2238630 |
84.49% |
2022-05-31
|
| Bellevue Group AG |
4808401 |
2.58% |
356708 |
8.01% |
2022-03-31
|
| Dimensional Fund Advisors, Inc. |
2002601 |
1.08% |
451433 |
29.10% |
2022-03-31
|
| Geode Capital Management, LLC |
2453464 |
1.32% |
95811 |
4.06% |
2022-03-31
|
| Fidelity Management & Research Company LLC |
3071438 |
1.65% |
-6494923 |
-67.89% |
2022-05-31
|
| SSGA Funds Management Inc |
3462463 |
1.86% |
-760205 |
-18.00% |
2022-05-31
|
| Camber Capital Management LLC |
4000000 |
2.15% |
250000 |
6.67% |
2022-03-31
|
| First Trust Advisors L.P. |
4390618 |
2.36% |
970889 |
28.39% |
2022-03-31
|
| Maverick Capital Ltd |
4792920 |
2.57% |
-1029684 |
-17.68% |
2022-03-31
|
| FMR Inc |
6759204 |
3.63% |
-7248541 |
-51.75% |
2021-12-31
|
| Bank of New York Mellon Corp |
1702700 |
0.91% |
-15685 |
-0.91% |
2021-12-31
|
| Fidelity Institutional Asset Management |
1689539 |
0.91% |
218473 |
14.85% |
2022-04-30
|
| Fidelity SelectCo, LLC |
2102371 |
1.13% |
54987 |
2.69% |
2022-04-30
|
| Wellington Management Group, LLP |
13392612 |
7.19% |
13392612 |
-- |
2020-12-31
|
| FMR LLC |
18949684 |
10.17% |
18949684 |
-- |
2020-12-31
|
| Invesco Ltd |
35456949 |
19.03% |
813563 |
2.35% |
2020-12-31
|
| SPDR State Street Global Advisors |
3208003 |
1.75% |
-101105 |
-3.06% |
2021-09-30
|
| Fidelity Management and Research Company |
16688001 |
9.08% |
-1145221 |
-6.42% |
2021-03-31
|
| Fidelity Management Trust Co |
2876365 |
1.58% |
-256518 |
-8.19% |
2021-04-30
|
| Fidelity Management & Research Company LLC |
12920770 |
7.20% |
-2494173 |
-16.18% |
2020-11-30
|
| Invesco Ltd. |
21984578 |
12.29% |
21984578 |
-- |
2019-05-31
|
| Fidelity Management & Research Company |
13753506 |
7.85% |
-3897405 |
-22.08% |
2020-05-31
|
| NORGES BANK |
2432006 |
1.39% |
493385 |
25.45% |
2019-12-31
|
| State Street Global Advisors |
2036026 |
1.16% |
-3012749 |
-59.67% |
2020-04-30
|
| Northern Trust Corp |
2004571 |
1.14% |
28591 |
1.45% |
2019-09-30
|
| Northern Trust Investments N A |
2004571 |
1.14% |
28591 |
1.45% |
2019-09-30
|
| Great Point Partners LLC |
2125000 |
1.21% |
2125000 |
-- |
2019-09-30
|
| HHG PLC |
2446263 |
1.40% |
-16597 |
-0.67% |
2019-06-30
|
| Invesco Capital Management LLC |
2721665 |
1.55% |
-460939 |
-14.48% |
2019-09-30
|
| OppenheimerFunds Inc |
17302891 |
9.87% |
-34 |
-- |
2019-03-31
|
| Invesco Ltd (OFI / OppenheimerFunds) |
24273042 |
13.85% |
2501294 |
11.49% |
2019-08-31
|
| BlackRock Japan Co Ltd |
2561904 |
1.47% |
-34990 |
-1.35% |
2019-05-31
|
| BlackRock Asset Management Canada Ltd |
5435526 |
3.12% |
6807 |
0.13% |
2019-05-31
|
| OFI Global Asset Management, Inc. |
17300000 |
9.93% |
-99564 |
-0.57% |
2019-04-30
|
| State Street Global Advisors (Aus) Ltd |
1904378 |
1.10% |
-65611 |
-3.33% |
2019-02-28
|
| Janus Capital Management LLC |
2476115 |
1.43% |
-415037 |
-14.36% |
2018-12-31
|
| BlackRock Institutional Trust Company NA |
3856787 |
2.23% |
-477502 |
-11.02% |
2018-06-30
|
| JPMorgan Chase & Co |
2139269 |
1.24% |
872354 |
68.86% |
2018-06-30
|
| State Street Corp |
6003908 |
3.48% |
-322695 |
-5.10% |
2018-06-30
|
| T. Rowe Price Associates, Inc. |
1924277 |
1.12% |
-1233956 |
-39.07% |
2018-06-30
|
| Invesco PowerShares Capital Mgmt LLC |
1249294 |
0.72% |
960623 |
332.77% |
2018-06-30
|
| Goldman, Sachs & Co. |
1338638 |
0.78% |
67921 |
5.35% |
2018-06-30
|
| Security Investors, LLC |
1007609 |
0.53% |
2275 |
0.23% |
2018-09-14
|
| Bridger Management LLC |
1134414 |
0.66% |
465922 |
69.70% |
2018-06-30
|
| Merrill Lynch & Co Inc |
595726 |
0.37% |
336286 |
129.62% |
2018-03-31
|
| Eagle Asset Management, Inc. |
1009601 |
0.62% |
-6491 |
-0.64% |
2018-03-31
|
| D. E. Shaw & Co LP |
730167 |
0.45% |
726274 |
18655.90% |
2018-03-31
|
| TIAA-CREF Investment Management LLC |
644401 |
0.40% |
18902 |
3.02% |
2018-03-31
|
| J.P. Morgan Investment Management Inc |
762469 |
0.47% |
-87419 |
-10.29% |
2018-03-31
|
| Invesco Advisers, Inc |
990959 |
0.61% |
-182553 |
-15.56% |
2018-03-31
|
| Duquesne Family Office LLC |
1192300 |
0.73% |
-641700 |
-34.99% |
2018-03-31
|
| Charles Schwab Investment Management Inc |
1158240 |
0.71% |
355766 |
44.33% |
2018-03-31
|
| Westfield Capital Management Company, LP |
1013932 |
0.62% |
-1279249 |
-55.78% |
2018-03-31
|
| Adage Capital Partners Gp LLC |
1219087 |
0.75% |
1080087 |
777.04% |
2018-03-31
|
| Principal Global Investors, LLC |
1406257 |
0.88% |
-51750 |
-3.55% |
2017-12-31
|
| Federated Global Inv Mgmt Corp |
1191400 |
0.75% |
163200 |
15.87% |
2017-12-31
|
| Polar Capital LLP |
975776 |
0.61% |
-42000 |
-4.13% |
2018-01-31
|
| Teachers Advisors Inc |
930424 |
0.58% |
256078 |
37.97% |
2017-12-31
|
| Rice Hall James & Associates, LLC |
1029332 |
0.65% |
-207977 |
-16.81% |
2017-12-31
|
| OppenheimerFunds, Inc. |
15094639 |
9.59% |
-9913681 |
-39.64% |
2017-11-30
|
| PointState Capital LP |
1580300 |
1.01% |
-150700 |
-8.71% |
2017-09-30
|
| Artal Group S A |
1250000 |
0.80% |
-150000 |
-10.71% |
2017-09-30
|
| Deutsche Bank AG |
1226733 |
0.78% |
748600 |
156.57% |
2017-09-30
|
| Rothschild Asset Management Inc |
1182422 |
0.75% |
56672 |
5.03% |
2017-09-30
|
| J P Morgan Asset Management (UK) Ltd |
1144248 |
0.72% |
4095 |
0.36% |
2017-09-30
|
| Charger Corp. |
2083429 |
1.36% |
2083429 |
-- |
2016-12-31
|
| Granahan Investment Management Inc.. |
1993125 |
1.45% |
12790 |
0.65% |
2016-09-30
|
| RA Capital Management, LLC |
3664154 |
2.66% |
439300 |
13.62% |
2016-09-30
|
| The Vanguard Group |
8304449 |
4.00% |
100483833 |
0.10% |
1999-11-30
|
| BlackRock, Inc. and certain subsidiaries |
8643319 |
4.00% |
104584160 |
0.10% |
1999-11-30
|
| OppenheimerFunds, Inc. and related entities |
24200000 |
4.00% |
292820000 |
0.20% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Principal SmallCap S&P 600 Idx SP |
901714 |
0.48% |
-7894 |
-0.87% |
2022-05-31
|
| Vanguard Small Cap Index |
4619651 |
2.48% |
-12482 |
-0.27% |
2022-05-31
|
| Vanguard Total Stock Market Index Fund |
5458211 |
2.93% |
-- |
-- |
2022-05-31
|
| First Trust NYSE Arca Biotech Fund |
7883597 |
4.23% |
-- |
-- |
2022-05-31
|
| PrimeCap Odyssey Aggressive Growth Fund |
10537680 |
5.66% |
-252080 |
-2.34% |
2022-03-31
|
| Vanguard Health Care Fund |
11383721 |
6.11% |
-- |
-- |
2022-03-31
|
| iShares Core S&P Small-Cap ETF |
12907896 |
6.93% |
18158 |
0.14% |
2022-05-31
|
| Invesco Global Multi Cap Growth |
35770000 |
19.20% |
-- |
-- |
2022-03-31
|
| Invesco Global Opportunities Fund |
35770000 |
19.20% |
-- |
-- |
2022-04-30
|
| BB Biotech AG |
2960676 |
1.59% |
340000 |
12.97% |
2022-03-31
|
| Vanguard Small Cap Growth Index Fund |
2834957 |
1.52% |
28003 |
1.00% |
2022-05-31
|
| PrimeCap Odyssey Growth Fund |
5193556 |
2.79% |
-90890 |
-1.72% |
2022-03-31
|
| State Street Russell Small/Mid Cap |
907914 |
0.49% |
6400 |
0.71% |
2022-05-31
|
| Fidelity |
924018 |
0.50% |
-67806 |
-6.84% |
2022-04-30
|
| Vanguard U.S. Opportunities Fund |
969186 |
0.52% |
-- |
-- |
2022-04-30
|
| iShares S&P Small-Cap 600 Growth ETF |
978807 |
0.53% |
-- |
-- |
2022-05-31
|
| iShares Biotechnology ETF |
1384815 |
0.74% |
-15316 |
-1.09% |
2022-05-31
|
| iShares S&P Small-Cap 600 Value ETF |
1799840 |
0.97% |
6555 |
0.37% |
2022-05-31
|
| Bellevue Healthcare |
1898607 |
1.02% |
1898607 |
-- |
2021-11-30
|
| Vanguard Extended Market Index Fund |
2461944 |
1.32% |
3103 |
0.13% |
2022-05-31
|
| Vanguard Tax Managed Small Cap Fund |
1419702 |
0.76% |
14500 |
1.03% |
2022-04-30
|
| Fidelity Growth Company Commingled Pool |
1008569 |
0.54% |
-44222 |
-4.20% |
2022-02-28
|
| Fidelity Advisor |
1268719 |
0.69% |
-21281 |
-1.65% |
2021-11-30
|
| Columbia Acorn Fund |
1064384 |
0.58% |
-248616 |
-18.93% |
2021-04-30
|
| SPDR |
1592900 |
0.86% |
3117 |
0.20% |
2021-11-30
|
| iShares Exponential Technologies ETF |
1106182 |
0.60% |
-- |
-- |
2021-11-30
|
| iShares Core S&P Mid-Cap ETF |
4993871 |
2.71% |
2094 |
0.04% |
2021-11-30
|
| Rhenman Healthcare Eq L/S |
1307196 |
0.72% |
-- |
-- |
2021-03-31
|
| iShares Nasdaq Biotechnology ETF |
1546344 |
0.85% |
-6960 |
-0.45% |
2021-05-28
|
| Invesco Global Opports Fund |
34750000 |
19.07% |
-250000 |
-0.71% |
2020-12-31
|
| OFI Global Global Multi Cap Growth |
35000000 |
19.51% |
2476999 |
7.62% |
2020-09-30
|
| iShares Core S&P Mid-Cap ETF |
4686919 |
2.61% |
2008 |
0.04% |
2020-11-27
|
| Invesco Oppenheimer Global Opports Fund |
32523001 |
18.18% |
-1000000 |
-2.98% |
2020-06-30
|
| Vanguard US Opportunities Fund |
1456884 |
0.83% |
-- |
-- |
2020-03-31
|
| State Street S&P Mid Cap Index Fund |
962900 |
0.55% |
-23800 |
-2.41% |
2020-01-31
|
| Invesco Oppenheimer Intl Sml-Mid Com Fd |
12000000 |
6.85% |
2237598 |
22.92% |
2019-09-30
|
| iShares S&P Mid-Cap 400 Value ETF |
1274086 |
0.73% |
-- |
-- |
2019-11-29
|
| Federated Kaufmann Fund |
1000000 |
0.57% |
1000000 |
-- |
2019-09-30
|
| Vanguard 500 Index Fund |
2936947 |
1.68% |
-532919 |
-15.36% |
2019-09-30
|
| Vanguard Institutional Index Fund |
1347198 |
0.77% |
-258179 |
-16.08% |
2019-09-30
|
| Invesco Oppenheimer Intl Dvrs Fd |
1352808 |
0.77% |
523087 |
63.04% |
2019-08-31
|
| Invesco S&P 500 |
1592902 |
0.91% |
-- |
-- |
2019-09-30
|
| Vanguard Mid-Cap Index Fund |
2158091 |
1.23% |
-28790 |
-1.32% |
2019-08-31
|
| iShares Core S&P 500 ETF |
1295967 |
0.74% |
1260 |
0.10% |
2019-08-30
|
| Vanguard Growth Index Fund |
1197508 |
0.69% |
1296 |
0.11% |
2019-05-31
|
| iShares Core S&P US Total Market ETF |
1280952 |
0.73% |
1155 |
0.09% |
2019-05-30
|
| iShares Core MSCI Kokusai ETF |
1280952 |
0.73% |
1155 |
0.09% |
2019-05-30
|
| Oppenheimer Global Opportunities Fund |
17300000 |
9.93% |
-- |
-- |
2019-03-31
|
| Vanguard Mid-Cap Growth Index Fund |
1045023 |
0.60% |
37286 |
3.70% |
2019-03-31
|
| iShares Russell 2000 Growth ETF |
1511584 |
0.87% |
2606 |
0.17% |
2018-06-21
|
| OH Putnam Fidelity Spartan 500 Index |
1296678 |
0.74% |
37521 |
2.98% |
2019-01-31
|
| iShares S&P Small-Cap 600 Growth ETF |
2129601 |
1.23% |
-- |
-- |
2018-03-15
|
| Vanguard Small Cap Index Fund |
1945264 |
1.12% |
16499 |
0.86% |
2018-05-31
|
| Vanguard Total Stock Mkt Idx |
4306448 |
2.50% |
17168 |
0.40% |
2018-07-31
|
| Vanguard Health Care Inv |
5364813 |
3.11% |
4030213 |
301.98% |
2018-06-30
|
| PRIMECAP Odyssey Growth |
7146656 |
4.15% |
-58815 |
-0.82% |
2018-06-30
|
| PRIMECAP Odyssey Aggressive Growth |
11934676 |
6.92% |
-138958 |
-1.15% |
2018-06-30
|
| Oppenheimer Global Opportunities A |
12000000 |
6.96% |
439984 |
3.81% |
2018-07-31
|
| Vanguard Mid Cap Index I |
4067907 |
2.36% |
27617 |
0.68% |
2018-07-31
|
| Vanguard 500 Index Inv |
2918913 |
1.69% |
6615 |
0.23% |
2018-07-31
|
| iShares Nasdaq Biotechnology |
1944350 |
1.07% |
-3702 |
-0.19% |
2018-09-12
|
| First Trust NYSE Arca Biotech ETF |
1524419 |
0.82% |
-- |
-- |
2018-09-13
|
| Vanguard Institutional Index I |
1558609 |
0.90% |
4049 |
0.26% |
2018-07-31
|
| Vanguard Growth Index Inv |
1206314 |
0.70% |
-3360 |
-0.28% |
2018-07-31
|
| Fidelity Spartan |
1073238 |
0.62% |
12658 |
1.19% |
2018-07-31
|
| Vanguard Mid-Cap Growth ETF |
1039673 |
0.60% |
2250 |
0.22% |
2018-07-31
|
| Health Care Select Sector SPDR |
816666 |
0.48% |
-207 |
-0.03% |
2018-09-05
|
| Janus Global Life Sciences D |
736147 |
0.45% |
-189512 |
-20.47% |
2018-03-31
|
| Janus Research D |
853400 |
0.53% |
853400 |
-- |
2018-03-31
|
| Janus Triton D |
905084 |
0.56% |
-539914 |
-37.36% |
2018-03-31
|
| Janus Forty S |
946982 |
0.58% |
946982 |
-- |
2018-03-31
|
| T. Rowe Price Health Sciences |
1548100 |
0.95% |
1548100 |
-- |
2018-03-31
|
| Vanguard Small Cap Growth Index Inv |
1102941 |
0.64% |
2302 |
0.21% |
2018-05-31
|
| iShares Russell 2000 Growth |
1334789 |
0.88% |
2594 |
0.19% |
2018-06-01
|
| Eagle Small Cap Growth A |
720425 |
0.45% |
123541 |
20.70% |
2018-03-31
|
| Principal SmallCap S&P 600 Idx SP |
913676 |
0.57% |
-- |
-- |
2018-02-28
|
| Vanguard Tax-Managed Small Cap Adm |
1214966 |
0.75% |
4300 |
0.36% |
2018-02-28
|
| Vanguard Extended Market Idx Inv |
2022538 |
1.26% |
11167 |
0.56% |
2018-02-28
|
| Columbia Small Cap Index Z |
796900 |
0.50% |
-- |
-- |
2018-02-28
|
| iShares S&P Small-Cap 600 Growth |
2129601 |
1.60% |
117173 |
5.82% |
2018-03-14
|
| Federated Kaufmann R |
1000000 |
0.63% |
70000 |
7.53% |
2017-12-31
|
| T. Rowe Price QM US Small-Cap Growth Eq |
861000 |
0.55% |
117200 |
15.76% |
2017-12-31
|
| PowerShares S&P SmallCap Health Care ETF |
444059 |
0.37% |
-- |
-- |
2018-01-25
|
| Dreyfus Small Cap Stock Index |
483079 |
0.31% |
-- |
-- |
2017-11-30
|
| CREF Stock R1 |
435762 |
0.28% |
163361 |
59.97% |
2017-11-30
|
| Invesco Small Cap Growth A |
1057083 |
0.67% |
1636 |
0.16% |
2017-09-30
|
| TIAA-CREF Small-Cap Equity Instl |
448300 |
0.28% |
117300 |
35.44% |
2017-11-30
|
| iShares S&P Small-Cap 600 Value |
934555 |
0.67% |
1307 |
0.14% |
2017-02-07
|
| JNL/Invesco Small Cap Growth B |
848035 |
0.62% |
20256 |
2.45% |
2016-09-30
|
| Vanguard Explorer Inv |
1242100 |
0.90% |
-38500 |
-3.01% |
2016-09-30
|
| iShares Core S&P Small-Cap (AU) |
3428599 |
3.20% |
4616 |
0.10% |
2015-11-19
|
| Vanguard US Opportunities |
2308400 |
1.70% |
-- |
-- |
2015-07-31
|
| iShares Russell 2000 (AU) |
2084327 |
2.00% |
-2628 |
-0.10% |
2015-11-19
|
| BlackRock Health Sciences Opps Port |
1999200 |
1.50% |
-- |
-- |
2015-10-31
|
| SPDR® S&P Pharmaceuticals ETF |
1711736 |
1.60% |
-- |
-- |
2015-11-19
|
| Oppenheimer Global Opportunities |
26400000 |
19.80% |
-- |
-- |
2015-09-30
|
| Janus Global Life Sciences Fund |
1474201 |
1.10% |
326124 |
28.40% |
2015-09-30
|
